EUVIMEDEUVIMED entdecken
Open Access

Prefusion stabilization of the Hendra and Langya virus F proteins

Patrick O Byrne iD, Elizabeth G Blade, Brian E Fisher, David R Ambrozak, Ajit R Ramamohan iD, Barney S Graham, Rebecca J Loomis iD, Jason S McLellan iD

Journal of Virology · 20.02.2024 · 98 (2)

DOI: 10.1128/jvi.01372-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 20.02.2024. Verfasst von Patrick O Byrne und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA. Hauptthemen laut MEDLINE: Hendra Virus, Henipavirus, Henipavirus Infections, Nipah Virus. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic henipaviruses such as Nipah virus (NiV) and Hendra virus (HeV) cause respiratory symptoms, with severe cases resulting in encephalitis, seizures, and coma. The work described here shows that the NiV and HeV fusion (F) proteins share common structural features with the F protein from an emerging henipavirus , Langya virus (LayV). Sequence alignment alone was sufficient to predict which known prefusion-stabilizing amino acid substitutions from NiV F would stabilize the prefusion conformations of HeV F and LayV F. This work also reveals an unexpected oligomeric interface shared by prefusion HeV F and NiV F. Together, these advances lay a foundation for future antigen design targeting henipavirus F proteins. In this way, Nipah virus can serve as a prototypical pathogen for the development of protective vaccines and monoclonal antibodies to prepare for potential henipavirus outbreaks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hendra VirusHenipavirusHenipavirus InfectionsNipah VirusViral ProteinsHumansGlycoproteinsPeptidesViral Fusion Proteins

Stichwörter der Autor:innen

HendraLangyaNipahelectron microscopyparamyxovirusprefusionstructure-based vaccine design

Substanzen

GlycoproteinsPeptidesViral Fusion ProteinsViral Proteins

Autor:innen und Institutionen

  • Department of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.
  • Viral Pathogenesis Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Morehouse School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Patrick O Byrne, Ajit R Ramamohan, Rebecca J Loomis, Jason S McLellan

Zitieren

APA

Byrne, P. O., Blade, E. G., Fisher, B. E., Ambrozak, D. R., Ramamohan, A. R., Graham, B. S., Loomis, R. J., & McLellan, J. S. (2024). Prefusion stabilization of the Hendra and Langya virus F proteins. Journal of Virology, 98(2). https://doi.org/10.1128/jvi.01372-23

Vancouver

Byrne PO, Blade EG, Fisher BE, Ambrozak DR, Ramamohan AR, Graham BS, et al. Prefusion stabilization of the Hendra and Langya virus F proteins. Journal of Virology. 2024;98(2). doi:10.1128/jvi.01372-23

BibTeX
@article{Byrne2024,
  author = {Byrne, Patrick O and Blade, Elizabeth G and Fisher, Brian E and Ambrozak, David R and Ramamohan, Ajit R and Graham, Barney S and Loomis, Rebecca J and McLellan, Jason S},
  title = {Prefusion stabilization of the Hendra and Langya virus F proteins},
  journal = {Journal of Virology},
  year = {2024},
  volume = {98},
  number = {2},
  doi = {10.1128/jvi.01372-23}
}
Kostenlos starten →